Bisoprolol: the pathway in the body

Bisoprolol is part of the pathway “Bisoprolol”. This page shows the whole pathway; the station of Bisoprolol is highlighted.

Where this laboratory value sits: Bisoprolol — tablet, swallowed. Bisoprolol is swallowed as a tablet. Unlike some other substances it is already the form that acts at the receptor; nothing has to be cleaved off first in the body. It keeps noradrenaline away from the β₁ receptor. Source 10

In brief

Bisoprolol is a beta blocker. It settles into the binding pocket of the β₁ receptor, where noradrenaline otherwise sits. Both share the same pocket: while bisoprolol sits in it, the chain up to cAMP starts more slowly. At the heart, the rate then slows.

The pathway step by step

Each station states what the compound does there. Three signs: ↑ supplies — builds up or makes available · ↓ depletes — inhibits, consumes or withholds · ↕ both, depending on amount. Behind it stands what the statement rests on: established physiology, observed in studies, or contested. The signs do not grade; they name the direction.

1. Bisoprolol → Uptake in the gut From the small bowel the substance passes into the blood. The label puts the absorbed share at roughly four fifths of the swallowed amount and notes that food does not change it. The liver intercepts little on the first pass. Source 10↑ supplies Most of the active substance passes into the blood. The liver intercepts only a little of it on the first pass, so almost everything absorbed reaches the circulation. established physiology Source 10
   ⚖ When the balance tips

   too much — If a lot of active substance passes into the blood, the amount there rises until the kidney and liver remove as much in the same time as is added.

   too little — If little active substance passes into the blood, the amount there stays low, and little bisoprolol arrives at the receptors.

   established physiology · Source 10

2. Uptake in the gut → Travelling in the blood In the blood only a small part is bound to protein; the rest is free and reaches the tissues. β₁ receptors sit among other places on the heart and on the pineal gland. Free, it is available to the receptors. Source 10, 4↑ supplies Because little is bound to protein, almost all of the active substance is freely available to the receptors. It spreads from the blood into the tissues. established physiology Source 10
   ⚖ When the balance tips

   too much — If a lot of free active substance is present, it reaches β₁ receptors in many tissues at once, at the heart as well as at the pineal gland.

   too little — If little free active substance is present, only a small share of the β₁ receptors at the heart and pineal gland is occupied.

   established physiology · Source 10, 4

3. Travelling in the blood → Elimination About half leaves the body unchanged in the urine, the other half is converted in the liver into inactive breakdown products. The enzyme CYP2D6 has no part in this. If one route slows, it stays longer in the blood. Source 10↓ depletes The kidney and liver remove the active substance from the blood along two routes side by side. How fast both work determines how long bisoprolol stays at the receptors. established physiology Source 10
   ⚖ When the balance tips

   too much — If the kidney and liver work briskly, the amount in the blood falls faster, and the receptors become free again sooner.

   too little — If the kidney or liver works more slowly, bisoprolol stays longer in the blood, and its amount there is higher.

   established physiology · Source 10

4. β₁ at the sinus node → cAMP and HCN channels adenylyl cyclase · Gs protein, Mg-ATP Adenylyl cyclase makes the messenger cAMP out of ATP. cAMP binds directly to the HCN channels of the sinus node; the more of it is bound, the sooner the next beat follows. Little cAMP slows the rate. Source 3↑ supplies cAMP makes the HCN channels open earlier. The pacemaker current starts sooner, the cell reaches the threshold for the next beat more quickly, and the heart beats faster. established physiology Source 3
   ⚖ When the balance tips

   too much — If a lot of cAMP is bound to the HCN channels, they open earlier in the pause between two beats; the pauses become shorter, and the rate rises.

   too little — If little cAMP is bound, the channels open later, the pacemaker current builds up more slowly, and the heartbeat slows.

   established physiology · Source 3

5. β₁ at the pineal gland → cAMP in the pinealocyte adenylyl cyclase · Gs protein, Mg-ATP Here too the Gs protein switches on adenylyl cyclase, and cAMP arises. The α₁ receptors act alongside it but do not carry the rise on their own. It switches on protein kinase A. Source 4, 1↑ supplies cAMP carries the night-time signal into the cell and switches on protein kinase A. Its amount determines how strongly the cell responds to noradrenaline. established physiology Source 4
   ⚖ When the balance tips

   too much — If a lot of cAMP forms, a lot of protein kinase A becomes active, and the cell makes a lot of AANAT.

   too little — If little cAMP forms, the kinase stays only weakly active, and the night-time rise in AANAT is smaller.

   established physiology · Source 4

6. cAMP in the pinealocyte → AANAT PKA and CREB cAMP switches on protein kinase A, and this in turn the regulator CREB. The amount of the enzyme AANAT then grows during the night. Because of this gait it carries the byname timezyme. Its amount is the bottleneck of melatonin formation. Source 4, 5↑ supplies AANAT is the bottleneck of melatonin formation: its amount determines how much serotonin becomes N-acetylserotonin at night. cAMP also keeps the enzyme from rapid breakdown. established physiology Source 4, 5
   ⚖ When the balance tips

   too much — If a lot of AANAT is present, a large share of the pineal gland's serotonin is acetylated, and serotonin in the gland falls at night.

   too little — If little AANAT is present, for example during the day or after light at night, serotonin remains in the gland, and hardly any melatonin forms.

   established physiology · Source 5

7. AANAT → N-acetylserotonin AANAT · acetyl-CoA AANAT hangs an acetyl group from acetyl-CoA onto serotonin. How much AANAT is present at that moment sets how much N-acetylserotonin arises in the night. ASMT makes melatonin from it. Source 5↑ supplies N-acetylserotonin is the immediate precursor of melatonin. ASMT converts it using a methyl group from SAM. established physiology Source 5, 4
   ⚖ When the balance tips

   too much — If a lot of N-acetylserotonin forms, ASMT can become the limiting step and help determine how much melatonin forms at night.

   too little — If little N-acetylserotonin forms, ASMT has little starting material, and little melatonin is made.

   observed in studies · Source 4

8. N-acetylserotonin → Melatonin ASMT · SAM The enzyme ASMT transfers a methyl group from SAM onto N-acetylserotonin. Melatonin leaves the pineal gland and spreads through the body with the blood. It rises in darkness and falls during the day. Source 4, 5↑ supplies Melatonin carries the message ‘night’ through the body: its amount in the blood rises in darkness and falls during the day, and tissues with melatonin receptors read the time of day from it. established physiology Source 4
   ⚖ When the balance tips

   too much — If a lot of melatonin is present, the night signal is strong; the liver breaks it down quickly, so the amount falls fast once formation ends.

   too little — If the night-time rise is small, the ‘night’ signal is weaker; under beta blockers a smaller night-time release is described.

   observed in studies · Source 4, 6

9. Tryptophan → Serotonin TPH, then AADC · iron and BH4, vit. B6 (PLP) Two enzymes lead there: tryptophan hydroxylase with iron and BH4 hangs on an OH group, then AADC with pyridoxal phosphate removes a carboxyl group. At night it is converted to melatonin in the pineal gland. Source 8, 9↑ supplies In the pineal gland serotonin is the starting material of AANAT. During the day it is present there in large amounts; at night a large share is converted to melatonin. established physiology Source 5, 8
   ⚖ When the balance tips

   too much — If a lot of serotonin is present, AANAT is well supplied with starting material at night; the amount of melatonin is then set by the enzyme, not by the store.

   too little — If little serotonin is present, for example because little tryptophan or pyridoxal phosphate is available, less N-acetylserotonin also forms at night.

   established physiology · Source 5, 9

Further stations

• Bisoprolol — tablet, swallowed Bisoprolol is swallowed as a tablet. Unlike some other substances it is already the form that acts at the receptor; nothing has to be cleaved off first in the body. It keeps noradrenaline away from the β₁ receptor. Source 10↓ depletes Bisoprolol keeps noradrenaline and adrenaline away from the β₁ receptor. At the heart, rate and force of contraction are therefore lower, at rest as well as during exertion. established physiology Source 10
  ⚖ When the balance tips

  too much — If a lot of bisoprolol is present, more β₁ receptors are occupied, and the heartbeat slows; with very large amounts the preference for β₁ is lost, and β₂ receptors in the airways and vessels are occupied as well.

  too little — If little bisoprolol is present, most receptors remain free; noradrenaline binds unhindered, and the heart and pineal gland respond as they would without the substance.

  established physiology · Source 10

• Occupied β₁ receptor — where noradrenaline sits Bisoprolol fits into the binding pocket of the β₁ receptor and sits there in place of noradrenaline. At β₂ receptors it binds far more weakly; the label calls this cardioselective. Less cAMP then forms at the heart. Source 10, 2, 1↓ depletes The occupied receptor does not bind noradrenaline and does not switch on the Gs protein. Less cAMP forms at the heart; the rate slows and the force of contraction becomes lower. established physiology Source 10, 2, 1
  ⚖ When the balance tips

  too much — If many β₁ receptors are occupied, even a lot of noradrenaline, for example during exertion, can speed up the heartbeat only a little.

  too little — If few receptors are occupied, noradrenaline binds largely unhindered, and the sympathetic nervous system sets rate and force as usual.

  established physiology · Source 10, 2

• β₁ at the sinus node — pacemaker of the heart The sinus node sets the beat of the heart. Noradrenaline binds there at the β₁ receptor; the coupled Gs protein switches on adenylyl cyclase. This is how the sympathetic nervous system speeds up the heart. Source 1, 3↑ supplies Through the β₁ receptor the sympathetic nervous system speeds up the heart: the Gs protein switches on adenylyl cyclase, and more cAMP forms in the sinus node. established physiology Source 1, 3
  ⚖ When the balance tips

  too much — If a lot of noradrenaline binds at the sinus node, a lot of cAMP forms, and the heartbeat becomes faster.

  too little — If little noradrenaline binds, for example at rest, the influence of the vagus nerve, which slows cAMP formation, predominates, and the rate stays slow.

  established physiology · Source 1, 3

• β₁ at the pineal gland — driven by nerves at night At night, nerve endings in the pineal gland release noradrenaline. It binds at β₁ and α₁ receptors of the pinealocytes, the cells of this gland. It is the starting signal for melatonin formation. Source 4↑ supplies Night-time noradrenaline is the starting signal for melatonin formation. Through this nerve the rhythm of the internal clock reaches the pineal gland. established physiology Source 4
  ⚖ When the balance tips

  too much — If a lot of noradrenaline arrives at night, the pineal gland makes a lot of AANAT and thus a lot of melatonin; light at night interrupts this signal.

  too little — If little noradrenaline arrives or the β₁ receptors are occupied, the night-time rise stays smaller; under beta blockers a smaller night-time release of melatonin is described.

  observed in studies · Source 4, 6

• Tryptophan — amino acid from food Tryptophan comes from the protein of food. It is the starting substance from which the body forms serotonin, and from that, in the pineal gland, melatonin. If little of it is available, less serotonin forms. Source 4↑ supplies Tryptophan supplies the framework from which serotonin, and from that melatonin, arise in the pineal gland. established physiology Source 4
  ⚖ When the balance tips

  too much — If a lot of tryptophan is available, the pineal gland forms more serotonin; how much of it becomes melatonin is still set by AANAT at night.

  too little — If little tryptophan is available, the pineal gland forms less serotonin, and less starting material is available to AANAT.

  established physiology · Source 4

What depends on the β₁ receptor

• Noradrenaline — Binds at the β₁ receptor; bisoprolol occupies the same pocket and sits there in its place; less cAMP then forms Source 1, 10
• Melatonin — The pineal gland governs AANAT through β₁ receptors; under beta blockers a smaller nightly release is described Source 4, 6, 7

What takes part in these steps

• Tryptophan — Amino acid at the start of the chain: serotonin arises from it, and from that melatonin in the pineal gland Source 4
• Serotonin — Starting substance of AANAT: N-acetylserotonin arises from serotonin; at night it is thus used up Source 5
• Vitamin B6 — As pyridoxal phosphate the cofactor of AADC, which makes serotonin out of 5-HTP; without PLP no serotonin Source 9
• Acetyl-CoA — Supplies AANAT with the acetyl group for N-acetylserotonin; without it no N-acetylserotonin Source 5
• SAM (from methionine) — Methyl group donor of ASMT, which converts N-acetylserotonin into melatonin; the last step to melatonin Source 4, 5
• ATP — Adenylyl cyclase makes cAMP out of it, the messenger behind the β₁ receptor; more cAMP, faster rate Source 1, 3

What the prescribing information states

Two placebo-controlled trials in the United States. Shown here is the subgroup within the usual amount range: 273 adults on bisoprolol and 132 on placebo. Listed are the events that occurred in at least 1 of 100 participants of the bisoprolol group — whether or not a connection with the substance was assumed. The figures apply to these trials.

How to read the table: what matters is the comparison within the row, not the single figure. For headache, dizziness, cough and sleeplessness the figure on placebo is higher than on bisoprolol. The two columns move clearly apart only for fatigue. There is no third column with another medicine here — this prescribing information compares against placebo alone.

In the same trials, 3.3 of 100 participants on bisoprolol stopped because of an event, and 6.8 of 100 on placebo. Across all worldwide trials and the reports after approval, the prescribing information carries a long list of further events, among them sleep disturbances and vivid dreams. For the reports after approval it notes that neither a frequency nor a causal relationship can be derived from them; they are therefore not listed here.

Sources

1. Motiejunaite J, Amar L, Vidal-Petiot E. Adrenergic receptors and cardiovascular effects of catecholamines. Ann Endocrinol (Paris) 2021 · PubMed 32473788
2. Taddei S, Tsabedze N, Tan RS. β-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications. Curr Med Res Opin 2024 · PubMed 38597065
3. DiFrancesco D. The funny current: cellular basis for the control of heart rate. Drugs 2007 · PubMed 17999560
4. Simonneaux V, Ribelayga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 2003 · PubMed 12773631
5. Klein DC. Arylalkylamine N-acetyltransferase: "the Timezyme". J Biol Chem 2007 · PubMed 17164235
6. Stoschitzky K, Sakotnik A, Lercher P et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999 · PubMed 10335905
7. Stoschitzky K, Stoschitzky G, Brussee H et al. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. Cardiology 2006 · PubMed 16679760
8. Roberts KM, Fitzpatrick PF. Mechanisms of tryptophan and tyrosine hydroxylase. IUBMB Life 2013 · PubMed 23441081
9. Paiardini A, Giardina G, Rossignoli G et al. New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5'-Phosphate Decarboxylases. Curr Med Chem 2017 · PubMed 27881066
10. US prescribing information (United States): Bisoprolol Fumarate Tablets, USP, DailyMed, version of 21 Apr 2026, sections DESCRIPTION and CLINICAL PHARMACOLOGY (Pharmacokinetics and Metabolism, Pharmacodynamics) · Prescribing information
11. US prescribing information (United States): Bisoprolol Fumarate Tablets, USP, DailyMed, version of 21 Apr 2026, section ADVERSE REACTIONS · Prescribing information

Whole pathway: Bisoprolol

As of 2026-09-25. Draft, written by Claude to schema v2; sources checked in PubMed; expert approval pending
Legal notice Privacy policy All biomarkers